BioSpace News Archive

BioPharmX Corporation (NYSE American: BPMX) (“BioPharmX” or the “Company”), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that, in anticipation of closing its merger with Timber Pharmaceuticals, it will effect a 1-for-12 reverse stock split of its outstanding common stock.

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), today announced that on May 14, 2020 the Company received a Paragraph IV Notice Letter from Apotex Inc. and Apotex Corp advising Supernus of the submission by Apotex of an Abbreviated New Drug Application to the U.S. Food and Drug Administration (FDA) seeking approval for oxcarbazepine extended-release tablets.

Proteostasis Therapeutics, Inc. (Nasdaq: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced financial results for the first quarter ended March 31, 2020 and provided a corporate update.

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2020 financial results and a Company update after the market closes on Wednesday, May 20, 2020

The COVID-19 pandemic triggered urgent testing needs globally. Given the nature and magnitude of this public health emergency in the USA, testing laboratories in the private sector are “all hands on deck” with frontline medical workers in large scale diagnostics testing for COVID-19 presence.

Genesis HealthCare (“Genesis”) (NYSE: GEN), one of the largest post-acute care providers in the United States, is announcing a change in the location of its 2020 Annual Meeting of Stockholders.

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, today announced financial results for the quarter ended March 31, 2020.

First published data with novel 1XX CAR signaling and programmed death-1 (PD-1) dominant negative receptor (DNR) checkpoint inhibition technologies

A case study published Thursday in the American Journal of Neuroradiology by physicians from Allegheny General Hospital (AGH) in Pittsburgh provides some of the first angiographic images documenting the rapid progression of acute ischemic stroke in a patient with the novel coronavirus (COVID-19).

Men of color in the United States are at an increased risk of prostate cancer and other prostate conditions, and despite advances in diagnosis and treatment, disparities still remain.